A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

PHASE1RecruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Advanced Solid TumorAdvanced Lymphoma
Interventions
DRUG

CS5001

The dose and dosing schedule is decided by the Safety Monitoring Committee.

BIOLOGICAL

Rituximab

IV infusion

DRUG

Gemcitabine

IV infusion

DRUG

Oxaliplatin

IV infusion

DRUG

Lenalidomide

PO

DRUG

Cyclophosphamide

IV infusion

DRUG

Doxorubicin

IV infusion

DRUG

Vincristine

IV infusion

DRUG

Prednisone

PO

Trial Locations (38)

2031

RECRUITING

Scientia Clinical Research Limited, Randwick

10032

RECRUITING

Columbia U. - Herbert Irving Comprehensive Cancer Center, New York

11733

RECRUITING

North Shore Hematology Oncology Associates, East Setauket

75201-7307

RECRUITING

BUMC - Mary Crowley Cancer Research Centers (MCCRC), Dallas

Unknown

TERMINATED

Ashford Cancer Centre Research, Adelaide

RECRUITING

Central Adelaide Local Health Network Incorporated, Adelaide

RECRUITING

Royal Adelaide Hospital (RAH), Adelaide

RECRUITING

Epworth Freemasons Medical Centre, East Melbourne

NOT_YET_RECRUITING

Epworth Foundation trading as Epworth HealthCare, Melbourne

NOT_YET_RECRUITING

Anhui Provincial Cancer Hospital, Hefei

NOT_YET_RECRUITING

Anhui Provincial Hospital,, Hefei

RECRUITING

Beijing Cancer Hospital, Beijing

TERMINATED

Beijing Cancer Hospital, Beijing

NOT_YET_RECRUITING

Yanda Lu Dao Pei Hospital, Beijing

RECRUITING

The Cancer Hospital Affiliated to Chongqing University, Chongqing

NOT_YET_RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Guangdong Province Hospital, Guangzhou

NOT_YET_RECRUITING

Sun YatSen University Cancer Center, Guangzhou

RECRUITING

Guangxi Medical University Affiliated Tumour Hospital, Nanning

RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

Henan Cancer Hospital, Zhengzhou

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

NOT_YET_RECRUITING

Jiangsu province hospital, Nanjing

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhu

NOT_YET_RECRUITING

Jiangxi Cancer Hospital, Nanchang

RECRUITING

The Second Hospital of Dalian Medical University, Dalian

NOT_YET_RECRUITING

The first Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

Shandong Cancer Hospital, Jinan

RECRUITING

Fudan University Shanghai Cancer Hospital, Shanghai

RECRUITING

Shanghai East Hospital, Shanghai

TERMINATED

Shanghai Pulmonary Hospital, Shanghai

NOT_YET_RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Tianjin

NOT_YET_RECRUITING

Yunnan Cancer Hospital, Kunming

RECRUITING

First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Sponsors
All Listed Sponsors
lead

CStone Pharmaceuticals

INDUSTRY